Answers are grounded in this paper and cite their sources.
Messenger RNA (mRNA)-based therapeutics have emerged as a promising strategy for restoring disease-associated protein function without the risk of genomic integration. Although lipid nanoparticles (LNPs) enable efficient intracellular delivery of therapeutic mRNAs, most anticancer studies have focused on the restoration of a single tumor suppressor, which may be insufficient for tumors harboring concurrent deficiencies in multiple tumor suppressor pathways. Here, we developed a dual mRNA-loaded protopanaxadiol-derived lipid nanoparticle (PPD-LNP) platform coencapsulating PTEN and p53 mRNAs (PTEN/p53m-LNPs) to simultaneously restore two complementary tumor suppressor functions in PTEN/TP53-deficient PC-3 prostate cancer cells. Both therapeutic mRNAs were designed using the same proprietary 5′ and 3′ untranslated region (UTR) architecture to provide a common mRNA expression framework for PTEN and p53. Treatment with PTEN/p53m-LNPs restored both PTEN and p53 protein expression and markedly reduced phosphorylated AKT (Ser473), consistent with suppression of PI3K/AKT signaling. Furthermore, p53 restoration was accompanied by increased expression of the canonical p53 downstream targets p21 and MDM2, providing molecular evidence of functional p53 activity. Compared with either single-mRNA formulation, dual mRNA delivery produced greater inhibition of cell viability, reduced clonogenic colony formation by approximately 89%, and significantly suppressed cell migration and invasion. These findings demonstrate that codelivery of dual therapeutic mRNAs using a single PPD-LNP enables simultaneous restoration of complementary tumor suppressor functions and enhanced antitumor activity. This study provides a proof-of-concept for multi-mRNA tumor suppressor restoration in cancer cells with concurrent tumor suppressor deficiencies.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: